Pindolol Tablet shortage
Pindolol Tablet is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 21, 2026.
Sun Pharmaceutical is permanently stopping production of pindolol tablets. Both the 5 mg and 10 mg strengths are still listed as available from other manufacturers, including Marlex Pharmaceuticals, ANI Pharmaceuticals, Westminster Pharmaceuticals, and Bryant Ranch Prepack.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Pindolol Tablet. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jan 30, 2026Currently in shortage2 of 2 products affected.
-
Jan 30, 2026First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Sun Pharmaceutical Industries, Inc. 📞 800-818-4555 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Pindolol, Tablet, 5 mg (NDC 57664-655-88) | — | — | Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027 | — |
| To Be Discontinued | Pindolol, Tablet, 10 mg (NDC 57664-656-88) | — | — | Discontinuation of the manufacture of the drug; Expiry date of last distributed batch October 2026 | — |
These rows are manufacturer reports to the FDA for Pindolol Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Pindolol Tablet? options further down this page.
Why is Pindolol Tablet in shortage?
Sun Pharmaceutical Industries has decided to permanently stop making their version of pindolol tablets — both the 5 mg and 10 mg strengths. They haven't shared a specific public reason for this decision. What this means practically is that the supply of these particular products is winding down, not running out all at once. The last batch of the 10 mg tablets (NDC 57664-656-88) that they distributed will expire in October 2026, and the last batch of the 5 mg tablets (NDC 57664-655-88) will expire in January 2027 — so those already-distributed pills will still be usable in pharmacies and homes until those dates.
It's worth knowing that this shortage report covers only Sun Pharmaceutical's products specifically. Other manufacturers of pindolol may be listed separately on this page.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Pindolol Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Pindolol Tablet?
Pindolol tablets are currently listed on the FDA drug-shortage list. I know that can feel unsettling, so let me walk you through what the report actually shows and the steps you can take.
Both strengths are affected. Neither the 5 mg nor the 10 mg tablet has an available source from the manufacturer on this record right now. The reason listed is that this manufacturer (Sun Pharmaceutical Industries) is discontinuing its production of pindolol. The last distributed batches carry expiry dates of October 2026 for the 10 mg and January 2027 for the 5 mg. Because this is a discontinuation rather than a temporary delay, the supply problem from this maker may be permanent — which makes a conversation with your prescriber the right next step.
Please keep in mind that this report reflects only one manufacturer. Other companies still make pindolol in both strengths, so your pharmacy may be able to source the same medicine elsewhere.
Here is what I suggest, in order:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to check wholesalers and other makers — the same medicine in both 5 mg and 10 mg is listed from makers such as ANI, Unichem, Marlex, and Westminster, though it may not be in local stock.
- If your exact strength cannot be found, ask your prescriber or pharmacist about a clinician-chosen option.
- Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls.
This is general information from national, manufacturer-reported data and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Pindolol Tablet?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Pindolol Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Pindolol | PINDOLOL 5 mg/1 | Tablet · Oral | Marlex Pharmaceuticals, Inc. | 10135-0743-01 |
| Pindolol | PINDOLOL 10 mg/1 | Tablet · Oral | Marlex Pharmaceuticals, Inc. | 10135-0744-01 |
| Pindolol | PINDOLOL 5 mg/1 | Tablet · Oral | ANI Pharmaceuticals, Inc. | 62559-0560-01 |
| Pindolol | PINDOLOL 10 mg/1 | Tablet · Oral | ANI Pharmaceuticals, Inc. | 62559-0561-01 |
| Pindolol | PINDOLOL 5 mg/1 | Tablet · Oral | Westminster Pharmaceuticals, LLC | 69367-0421-01 |
| Pindolol | PINDOLOL 10 mg/1 | Tablet · Oral | Westminster Pharmaceuticals, LLC | 69367-0422-01 |
| Pindolol | PINDOLOL 5 mg/1 | Tablet · Oral | Bryant Ranch Prepack | 72162-2652-01 |
| Pindolol | PINDOLOL 10 mg/1 | Tablet · Oral | Bryant Ranch Prepack | 72162-2653-01 |
| Pindolol | PINDOLOL 10 mg/1 | Tablet · Oral | PD-Rx Pharmaceuticals, Inc. | 72789-0099-01 |
| Pindolol | PINDOLOL 5 mg/1 | Tablet · Oral | PD-Rx Pharmaceuticals, Inc. | 72789-0100-01 |
| Pindolol | PINDOLOL 5 mg/1 | Tablet · Oral | Unichem Pharmaceuticals (USA), Inc. | 76385-0131-01 |
| Pindolol | PINDOLOL 10 mg/1 | Tablet · Oral | Unichem Pharmaceuticals (USA), Inc. | 76385-0132-01 |
Therapeutic equivalents & pricing 17 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Pindolol 5 mg | Sun | 100 tablets | $0.640 | AB | Availability likely |
| Pindolol 5 mg | ANI | 100 tablets | $0.640 | AB | Availability likely |
| Pindolol 5 mg | Westminster | 100 tablets | $0.640 | AB | Availability likely |
| Pindolol 5 mg | Unichem | 100 tablets | $0.640 | AB | Availability likely |
| Pindolol 10 mg | Sun | 100 tablets | $0.855 | AB | Availability likely |
| Pindolol 10 mg | ANI | 100 tablets | $0.855 | AB | Availability likely |
| Pindolol 10 mg | Westminster | 100 tablets | $0.855 | AB | Availability likely |
| Pindolol 10 mg | Unichem | 100 tablets | $0.855 | AB | Availability likely |
| Pindolol 5 mg | Marlex | 100 tablets | — | AB | FDA listed |
| Pindolol 5 mg | Bryant | 180 tablets | — | AB | FDA listed |
| Pindolol 5 mg | Bryant | 100 tablets | — | AB | FDA listed |
| Pindolol 5 mg | PD-Rx | 100 tablets | — | AB | FDA listed |
| Pindolol 5 mg | PD-Rx | 100 tablets | — | AB | FDA listed |
| Pindolol 10 mg | Marlex | 100 tablets | — | AB | FDA listed |
| Pindolol 10 mg | Bryant | 100 tablets | — | AB | FDA listed |
| Pindolol 10 mg | PD-Rx | 100 tablets | — | AB | FDA listed |
| Pindolol 10 mg | PD-Rx | 100 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Pindolol Tablet — that fall in the same broad treatment class (beta-adrenergic blocking agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other cardiovascular shortages
Pindolol Tablet shortage FAQs
Is Pindolol Tablet in shortage?
Which products are affected?
When will Pindolol Tablet be available again?
Can I still get Pindolol somewhere?
What should I do if I take Pindolol Tablet?
Still have a question about the Pindolol Tablet shortage?
Ask a pharmacist about this shortage →View Pindolol Tablet on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.